+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Rheumatoid Arthritis Drugs Market 2022-2026

  • ID: 5578831
  • Report
  • April 2022
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Cyxone AB
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Kangstem Biotech Co. Ltd.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the rheumatoid arthritis drugs market and it is poised to grow by $14.90 bn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period. The report on the rheumatoid arthritis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by unmet needs for safer biologics for RA, the availability of improved diagnostic modalities, and the need for affordable biologics for RA.

The rheumatoid arthritis drugs market analysis includes the type segment and geographic landscape.

The rheumatoid arthritis drugs market is segmented as below:

By Type

  • Biologics
  • Small molecules

By Geography

  • Europe
  • North America
  • Asia
  • Rest of World (ROW)

This study identifies the high cost of RA drugs as one of the prime reasons driving the rheumatoid arthritis drugs market growth during the next few years. Also, the use of biologics/biosimilars for the treatment of RA and the use of gene therapy for RA treatment will lead to sizable demand in the market.

The report on rheumatoid arthritis drugs market covers the following areas:

  • Rheumatoid arthritis drugs market sizing
  • Rheumatoid arthritis drugs market forecast
  • Rheumatoid arthritis drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rheumatoid arthritis drugs market vendors that include AbbVie Inc., Amgen Inc., Astellas Pharma Inc., Bristol Myers Squibb Co., Cyxone AB, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Galmed Pharmaceuticals Ltd., Genor BioPharma Holding Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson, Kangstem Biotech Co. Ltd., Novartis AG, Oryn Therapeutics, Pfizer Inc., Sanofi, Sorrento Therapeutics Inc., Taisho Pharmaceutical Holdings Co. Ltd., and UCB SA. Also, the rheumatoid arthritis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Cyxone AB
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Kangstem Biotech Co. Ltd.

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Biologics - Market size and forecast 2021-2026
Exhibit 28: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Biologics - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
5.4 Small molecules - Market size and forecast 2021-2026
Exhibit 32: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share by geography 2021-2026 (%)
Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 Europe - Market size and forecast 2021-2026
Exhibit 42: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.4 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 France - Market size and forecast 2021-2026
Exhibit 70: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on France - Year-over-year growth 2021-2026 (%)
7.11 China - Market size and forecast 2021-2026
Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity by geography
Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 85: AbbVie Inc. - Overview
Exhibit 86: AbbVie Inc. - Product / Service
Exhibit 87: AbbVie Inc. - Key offerings
10.4 Amgen Inc.
Exhibit 88: Amgen Inc. - Overview
Exhibit 89: Amgen Inc. - Product / Service
Exhibit 90: Amgen Inc. - Key offerings
10.5 Bristol Myers Squibb Co.
Exhibit 91: Bristol Myers Squibb Co. - Overview
Exhibit 92: Bristol Myers Squibb Co. - Product / Service
Exhibit 93: Bristol Myers Squibb Co. - Key offerings
10.6 Eli Lilly and Co.
Exhibit 94: Eli Lilly and Co. - Overview
Exhibit 95: Eli Lilly and Co. - Product / Service
Exhibit 96: Eli Lilly and Co. - Key offerings
10.7 F. Hoffmann La Roche Ltd.
Exhibit 97: F. Hoffmann La Roche Ltd. - Overview
Exhibit 98: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 99: F. Hoffmann La Roche Ltd. - Key news
Exhibit 100: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 101: F. Hoffmann La Roche Ltd. - Segment focus
10.8 Johnson and Johnson
Exhibit 102: Johnson and Johnson - Overview
Exhibit 103: Johnson and Johnson - Business segments
Exhibit 104: Johnson and Johnson - Key news
Exhibit 105: Johnson and Johnson - Key offerings
Exhibit 106: Johnson and Johnson - Segment focus
10.9 Novartis AG
Exhibit 107: Novartis AG - Overview
Exhibit 108: Novartis AG - Business segments
Exhibit 109: Novartis AG - Key offerings
Exhibit 110: Novartis AG - Segment focus
10.10 Pfizer Inc.
Exhibit 111: Pfizer Inc. - Overview
Exhibit 112: Pfizer Inc. - Product / Service
Exhibit 113: Pfizer Inc. - Key news
Exhibit 114: Pfizer Inc. - Key offerings
10.11 Sanofi
Exhibit 115: Sanofi - Overview
Exhibit 116: Sanofi - Business segments
Exhibit 117: Sanofi - Key news
Exhibit 118: Sanofi - Key offerings
Exhibit 119: Sanofi - Segment focus
10.12 UCB SA
Exhibit 120: UCB SA - Overview
Exhibit 121: UCB SA - Product / Service
Exhibit 122: UCB SA - Key offerings
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 123: Inclusions checklist
Exhibit 124: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 125: Currency conversion rates for US$
11.4 Research methodology
Exhibit 126: Research methodology
Exhibit 127: Validation techniques employed for market sizing
Exhibit 128: Information sources
11.5 List of abbreviations
Exhibit 129: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Type - Market share 2021-2026 (%)
Exhibits 25: Data Table on Type - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Type
Exhibits 27: Data Table on Comparison by Type
Exhibits 28: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits 36: Market opportunity by Type ($ million)
Exhibits 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 38: Chart on Market share by geography 2021-2026 (%)
Exhibits 39: Data Table on Market share by geography 2021-2026 (%)
Exhibits 40: Chart on Geographic comparison
Exhibits 41: Data Table on Geographic comparison
Exhibits 42: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 43: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 44: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 45: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 78: Market opportunity by geography ($ million)
Exhibits 79: Impact of drivers and challenges in 2021 and 2026
Exhibits 80: Overview on Criticality of inputs and Factors of differentiation
Exhibits 81: Overview on factors of disruption
Exhibits 82: Impact of key risks on business
Exhibits 83: Vendors covered
Exhibits 84: Matrix on vendor position and classification
Exhibits 85: AbbVie Inc. - Overview
Exhibits 86: AbbVie Inc. - Product / Service
Exhibits 87: AbbVie Inc. - Key offerings
Exhibits 88: Amgen Inc. - Overview
Exhibits 89: Amgen Inc. - Product / Service
Exhibits 90: Amgen Inc. - Key offerings
Exhibits 91: Bristol Myers Squibb Co. - Overview
Exhibits 92: Bristol Myers Squibb Co. - Product / Service
Exhibits 93: Bristol Myers Squibb Co. - Key offerings
Exhibits 94: Eli Lilly and Co. - Overview
Exhibits 95: Eli Lilly and Co. - Product / Service
Exhibits 96: Eli Lilly and Co. - Key offerings
Exhibits 97: F. Hoffmann La Roche Ltd. - Overview
Exhibits 98: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 99: F. Hoffmann La Roche Ltd. - Key news
Exhibits 100: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 101: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 102: Johnson and Johnson - Overview
Exhibits 103: Johnson and Johnson - Business segments
Exhibits 104: Johnson and Johnson - Key news
Exhibits 105: Johnson and Johnson - Key offerings
Exhibits 106: Johnson and Johnson - Segment focus
Exhibits 107: Novartis AG - Overview
Exhibits 108: Novartis AG - Business segments
Exhibits 109: Novartis AG - Key offerings
Exhibits 110: Novartis AG - Segment focus
Exhibits 111: Pfizer Inc. - Overview
Exhibits 112: Pfizer Inc. - Product / Service
Exhibits 113: Pfizer Inc. - Key news
Exhibits 114: Pfizer Inc. - Key offerings
Exhibits 115: Sanofi - Overview
Exhibits 116: Sanofi - Business segments
Exhibits 117: Sanofi - Key news
Exhibits 118: Sanofi - Key offerings
Exhibits 119: Sanofi - Segment focus
Exhibits 120: UCB SA - Overview
Exhibits 121: UCB SA - Product / Service
Exhibits 122: UCB SA - Key offerings
Exhibits 123: Inclusions checklist
Exhibits 124: Exclusions checklist
Exhibits 125: Currency conversion rates for US$
Exhibits 126: Research methodology
Exhibits 127: Validation techniques employed for market sizing
Exhibits 128: Information sources
Exhibits 129: List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Cyxone AB
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Kangstem Biotech Co. Ltd.
The publisher recognizes the following companies as the key players in the global rheumatoid arthritis drugs market: AbbVie Inc., Amgen Inc., Astellas Pharma Inc., Bristol Myers Squibb Co., Cyxone AB, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Galmed Pharmaceuticals Ltd., Genor BioPharma Holding Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson, Kangstem Biotech Co. Ltd., Novartis AG, Oryn Therapeutics, Pfizer Inc., Sanofi, Sorrento Therapeutics Inc., Taisho Pharmaceutical Holdings Co. Ltd., and UCB SA.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is high cost of RA drugs.`

According to the report, one of the major drivers for this market is the unmet needs for safer biologics for RA.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.


Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • Bristol Myers Squibb Co.
  • Cyxone AB
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Galmed Pharmaceuticals Ltd.
  • Genor BioPharma Holding Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson
  • Kangstem Biotech Co. Ltd.
  • Novartis AG
  • Oryn Therapeutics
  • Pfizer Inc.
  • Sanofi
  • Sorrento Therapeutics Inc.
  • Taisho Pharmaceutical Holdings Co. Ltd.
  • UCB SA
Note: Product cover images may vary from those shown